TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Pfizer Anti-Infectives AB
Closing information (x1000 DKK)
| Closing information | 2022/11 | 2021/11 | 2020/11 |
| Turnover |
921,047
|
240,138
|
1,119,731 |
| Financial expenses |
321
|
921
|
1 |
| Earnings before taxes |
282,578
|
-412,125
|
895,339 |
| EBITDA |
323,188
|
-368,198 | |
| Total assets |
1,075,813
|
830,257
|
1,248,697 |
| Current assets |
76,473
|
158,161
|
741 |
| Current liabilities |
425,854
|
375,932
|
460,573 |
| Equity capital |
649,959
|
454,325
|
788,124 |
| - share capital |
34
|
36
|
37 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2022/11 | 2021/11 | 2020/11 |
| Solvency |
60.4%
|
54.7%
|
63.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
30.7%
|
-171.6%
|
80.0% |
| Return on assets (ROA) |
26.3%
|
-49.5%
|
71.7% |
| Current ratio |
18.0%
|
42.1%
|
0.2% |
| Return on equity (ROE) |
43.5%
|
-90.7%
|
113.6% |
| Change turnover |
696,089
|
-870,267
|
1,119,731 |
| Change turnover % |
309%
|
-78% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2022/11 | 2021/11 | 2020/11 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.